diseas
still
regard
major
constraint
aquacultur
product
global
rapid
diseas
diagnosi
vaccin
play
huge
part
control
bacteri
diseas
signifi
cant
progress
area
chapter
consid
limit
exist
method
review
recent
advanc
made
pathogen
detect
technolog
vaccin
develop
methodolog
futur
direct
discuss
includ
nanotechnolog
revers
vaccinolog
diseas
still
regard
major
constraint
aquacultur
product
global
adam
et
al
industri
continu
expand
diversifi
risk
new
diseas
emerg
old
one
spread
geograph
region
realiti
movement
egg
fri
fi
sh
farm
present
ideal
circumst
pathogen
adapt
host
environ
control
pathogen
complex
reli
heavili
combin
pathogen
detect
diseas
diagnosi
treatment
prevent
gener
health
manag
rapid
diseas
diagnosi
vaccin
play
huge
part
signifi
cant
progress
area
sinc
year
sinc
pace
increas
even
method
develop
clinic
veterinari
medicin
rapidli
adapt
optimis
use
aquacultur
novel
diagnost
method
publish
frequent
success
vaccin
reduc
use
antibiot
realis
least
countri
innov
altern
method
control
fi
sh
diseas
also
research
appli
chapter
aim
provid
review
recent
advanc
made
diseas
diagnosi
vaccin
develop
emerg
method
control
pathogen
aquacultur
main
key
driver
improv
diseas
diagnosi
vaccin
develop
continu
signifi
cant
loss
industri
caus
pathogen
bacteri
diseas
caus
substanti
econom
burden
aquacultur
industri
although
antibiot
chemotherapeut
extens
use
control
diseas
outbreak
increas
concern
use
drug
residu
food
develop
antimicrobi
drug
resist
detriment
effect
aquat
microbi
ecosystem
popul
thompson
adam
concert
effort
move
away
use
antibiot
wherev
possibl
highlight
septemb
korea
announc
next
year
korea
food
drug
administr
ban
use
seven
type
antibiot
feed
livestock
fi
sh
rais
fi
sh
farm
uk
norway
japan
alreadi
signifi
cant
reduct
use
antibiot
sinc
adam
et
al
markestad
grave
real
need
increas
product
fi
sh
global
aquacultur
therefor
health
welfar
must
given
high
prioriti
target
set
reach
vaccin
particular
multival
vaccin
led
welfar
concern
past
year
due
presenc
adhes
intern
organ
thought
result
oilbas
adjuv
vaccin
berg
et
al
farm
new
speci
play
signifi
cant
role
increas
product
persist
diseas
problem
cod
vibriosi
particular
play
larg
part
new
industri
stagnat
scotland
cobia
farm
increas
global
fi
rst
farm
licens
brazil
eric
routledg
special
secretariat
aquacultur
fisheri
seap
brazil
per
comm
need
farmer
one
step
ahead
potenti
diseas
threat
mani
current
techniqu
detect
pathogen
diagnosi
diseas
actual
good
hand
identifi
cation
certain
pathogen
diffi
cult
achiev
method
develop
may
complic
appli
interpret
convent
pathogen
isol
characteris
techniqu
alongsid
patholog
still
remain
method
choic
diagnosi
mani
diseas
howev
tradit
method
tend
costli
labourintens
slow
might
alway
lead
defi
nitiv
diagnosi
made
rapid
progress
made
biotechnolog
sinc
enabl
develop
improv
wide
rang
immunodiagnost
molecular
techniqu
cunningham
thompson
reagent
commerci
kit
becom
wide
avail
rapid
method
complement
enhanc
tradit
method
diseas
diagnosi
manual
diagnost
test
aquat
anim
world
organis
anim
health
includ
varieti
standardis
method
includ
tradit
immunolog
molecular
method
identifi
cation
select
pathogen
caus
notifi
abl
diseas
expand
new
method
develop
valid
adam
thompson
howev
viral
diseas
renibacteriun
salmoninarum
piscirickettsia
salmoni
caus
agent
bacteri
kidney
diseas
bkd
ricketsiosi
respect
bacteri
pathogen
includ
diseas
caus
pathogen
meet
list
criteria
includ
report
requir
nonlist
diseas
appli
regard
signifi
cant
epidemiolog
event
diseas
includ
anim
health
code
set
standard
import
reagent
method
use
detect
bacteri
pathogen
standardis
rigor
test
specifi
citi
sensit
commerci
reagent
kit
develop
adam
thompson
gone
way
achiev
still
full
rang
reagent
kit
avail
use
aquacultur
cost
speed
specifi
citi
sensit
assay
extrem
import
endus
highest
cost
often
time
although
labour
cost
vari
consider
countri
mani
new
technolog
requir
specialis
equip
highli
skill
staff
exist
methodolog
suit
fi
eld
test
use
rudimentari
laboratori
diseas
diagnosi
current
made
use
varieti
method
review
adam
thompson
tradit
bacteriolog
wherebi
pathogen
isol
identifi
ed
biochem
eg
use
strip
observ
histolog
section
diseas
fi
sh
wide
use
rapid
method
specifi
calli
identifi
pathogen
use
antibodi
immunodiagnost
amplifi
specifi
c
sequenc
dna
rna
use
polymeras
chain
reaction
pcr
ie
molecular
diagnost
also
regularli
use
mani
laboratori
instanc
molecular
diagnost
complet
taken
methodolog
mani
rapid
method
live
dead
pathogen
distinguish
therefor
inclus
enrich
method
use
livedead
kit
use
supplementari
method
vatso
et
al
interpret
result
use
rapid
method
pathogen
detect
care
consid
clinic
evid
includ
histolog
attempt
cultur
pathogen
immunodiagnost
method
immunohistochemistri
ihc
fl
uoresc
antibodi
test
fat
indirect
fl
uoresc
antibodi
test
ifat
enabl
rapid
specifi
c
detect
pathogen
tissu
sampl
without
need
fi
rst
isol
pathogen
ihc
method
simpl
extens
histolog
allow
specifi
c
identifi
cation
pathogen
formalin
tissu
fi
xed
section
adam
marin
de
mateo
steiropoulo
et
al
fatifat
extrem
rapid
sensit
well
specifi
c
requir
fl
uoresc
microscop
read
result
adam
et
al
mile
et
al
klesiu
et
al
ihc
fatifat
technic
easi
perform
exampl
result
obtain
use
method
shown
fig
p
see
also
colour
section
varieti
antibodybas
method
also
develop
use
aquacultur
simpl
use
usual
requir
pathogen
isol
prior
use
lack
sensit
eg
agglutin
other
complex
ad
advantag
pathogen
quantifi
cation
eg
enzymelink
immunosorb
assay
elisa
detect
characteris
specifi
c
pathogen
antigen
molecular
weight
eg
western
blot
rose
et
al
adam
thompson
adam
adam
elisa
also
advantag
high
throughput
autom
equip
avail
elisa
also
use
serolog
detect
antibodi
specifi
c
pathogen
although
serolog
essenti
screen
tool
clinic
medicin
control
programm
signifi
cant
diseas
domest
anim
palmerdensmor
et
al
yuce
et
al
fournier
raoult
yet
valid
bacteri
diseas
fi
sh
serolog
use
effect
detect
exposur
fi
sh
virus
koi
herpesviru
khv
adkinson
et
al
adam
thompson
bacteri
pathogen
pose
much
complex
pictur
cross
reactiv
like
unless
specifi
c
known
protein
use
coat
elisa
plate
rather
whole
pathogen
use
molecular
technolog
detect
fi
sh
bacteri
pathogen
rapidli
increas
vast
array
method
alreadi
develop
karunasagar
et
al
cunningham
thompson
wilson
carson
molecular
method
gener
highest
sensit
therefor
particularli
use
detect
microorgan
present
low
number
diffi
cult
cultur
addit
molecular
method
use
identifi
cation
pathogen
speci
level
puttinaowarat
et
al
pourahm
epidemiolog
identifi
cation
individu
strain
differenti
close
relat
strain
cowley
et
al
pcr
best
known
method
although
mani
use
variat
includ
nest
pcr
random
amplifi
cation
polymorph
dna
rapd
revers
transcriptasepcr
rtpcr
revers
cross
blot
pcr
rcbpcr
rtpcr
enzym
hybridis
assay
puttinaowarat
et
al
wilson
carson
cunningham
coloni
hybridis
also
use
success
rapid
identifi
cation
vibrio
anguillarum
fi
sh
aoki
et
al
advantag
detect
pathogen
environment
strain
powel
loutit
realtim
pcr
also
known
qpcr
offer
quantifi
cation
high
sampl
throughput
real
jansson
et
al
edwardsiella
ictaluri
us
patent
like
rang
expand
rapidli
polygen
sequenc
follow
pcr
specifi
c
gene
recommend
identifi
cation
pathogen
differenti
close
relat
speci
difficult
exampl
pourahm
found
sequenc
three
differ
gene
necessari
classifi
certain
mycobacteria
speci
fi
sh
varieti
novel
rapid
diagnost
method
current
develop
potenti
futur
applic
diagnosi
aquat
anim
health
recent
review
adam
thompson
comparison
made
method
exist
technolog
regard
advantag
disadvantag
loopmedi
isotherm
amplifi
cation
lamp
emerg
technolog
potenti
detect
fi
sh
shellfi
sh
pathogen
research
test
detect
edwardsiella
tarda
e
ictaluri
nocardia
seriola
flavobacterium
psychrophilum
bacteri
pathogen
caus
edwardsielloi
enter
septicemia
catfi
sh
nocardiosi
respect
tetracapsuloid
bryosalmona
parasit
caus
prolif
kidney
diseas
pkd
infecti
haematopoit
necrosi
viru
ihnv
fi
sh
white
spot
syndrom
viru
wwsv
shrimp
alreadi
develop
savan
et
al
manji
commerci
lamp
test
kit
avail
wssv
lamp
rel
new
method
amplifi
dna
reli
autocycl
strand
displac
dna
synthesi
sinc
carri
isotherm
condit
perform
without
use
thermocycl
method
use
bst
dna
polymeras
set
four
special
design
primer
two
inner
two
outer
primer
recognis
total
six
distinct
sequenc
templat
dna
notomi
et
al
main
advantag
method
speed
perform
sensit
fact
result
read
eye
although
test
requir
use
pipett
incub
requir
specialis
equip
figur
p
see
also
colour
section
show
result
lamp
test
carri
identifi
flavobacterium
psychrophilum
simpl
colour
chang
tube
orang
green
indic
posit
simpl
rapid
fi
eld
test
use
later
fl
ow
technolog
also
develop
rapid
kit
current
commerci
avail
detect
infecti
salmon
anaemia
viru
isav
wssv
shrimp
although
none
yet
bacteri
pathogen
fi
sh
type
technolog
success
develop
clinic
gatta
et
al
veterinari
use
bautista
et
al
offer
simpl
fi
eld
test
capabl
also
interest
develop
multiplex
test
simultan
detect
differ
pathogen
singl
sampl
multiplex
technolog
luminex
xmap
tm
bead
array
microarray
huge
potenti
area
current
expens
labourintens
assay
still
develop
optimis
adam
thompson
xmap
system
theoret
offer
simultan
quantit
analysi
differ
analyt
singl
drop
sampl
integr
format
system
dunbar
complex
technolog
huge
potenti
use
vaccin
develop
epitop
map
costa
et
al
well
pathogen
detect
fl
exibl
technolog
antibodi
protein
dna
bound
bead
array
number
research
group
also
current
develop
dna
oligo
microarray
technolog
diagnost
also
offer
simultan
detect
pathogen
futur
et
al
matsuyama
et
al
wide
rang
commerci
vaccin
avail
bacteri
pathogen
target
salmon
trout
addit
vaccin
avail
channel
catfi
sh
european
seabass
seabream
japanes
amberjack
yellowtail
tilapia
atlant
cod
thompson
adam
adam
et
al
sommerset
et
al
thompson
adam
adam
et
al
primari
consider
vaccin
aquacultur
costeffect
safeti
vaccin
need
provid
longterm
protect
diseas
commerci
fi
sh
farm
serotyp
variant
diseas
agent
need
consid
timeag
anim
suscept
diseas
rout
administr
method
vaccin
prepar
ie
inactiv
whole
cell
attenu
subunit
recombin
order
develop
effect
vaccin
protect
antigen
need
identifi
ed
protect
respons
confi
rmed
host
speci
latter
may
antibodi
mediat
cell
mediat
depend
vaccin
compon
practic
method
administr
inexpens
method
vaccin
product
also
need
establish
import
vaccin
develop
work
antigen
express
infect
rather
antigen
express
laboratori
mani
salmon
vaccin
past
base
inactiv
whole
cell
cultur
pathogen
organ
usual
inactiv
formalin
grown
vitro
case
vaccin
gave
good
protect
eg
vibrio
vaccin
howev
mani
pathogen
appear
switch
import
protect
antigen
cultur
vitro
case
altern
method
cultur
eg
inclus
ironchel
agent
requir
express
import
protect
antigen
induc
neelam
et
al
achiev
modifi
cultur
medium
pathogen
vitro
shown
bakopoulo
et
al
jung
et
al
photobacterium
damsela
subsp
piscicida
pathogen
caus
pasteurellosi
effect
alter
constitu
media
cultur
p
damsela
subsp
piscicida
laboratori
antigen
express
illustr
fig
differ
observ
antigen
expressedrecognis
fi
sh
sera
media
exampl
fig
b
antigen
appear
upregul
whilst
other
downregul
also
serv
highlight
differ
mammalian
fi
sh
immun
system
fi
sh
fig
recognis
mani
fewer
antigen
rabbit
fig
altern
approach
place
pathogen
interest
insid
periton
caviti
fi
sh
enclos
seal
chamber
permit
exchang
small
molecul
antigen
express
vivo
determin
bakopoulo
et
al
poobalan
jung
et
al
figur
show
r
salmoninarum
alter
express
surfac
molecul
bacterium
cultur
vivo
vitro
bacteri
cell
appear
smooth
round
cultur
vitro
contrast
cultur
insid
host
fi
sh
applic
sera
fi
sh
infect
diseas
interest
recov
western
blot
analysi
oneor
twodimension
gel
immunoprotom
pinpoint
potenti
vaccin
candid
identifi
ed
vaccin
produc
eg
recombin
vaccin
aeromona
hydrophila
poobalan
cours
antigen
may
express
fi
sh
may
respond
produc
antibodi
may
may
protect
thu
challeng
vaccin
nonvaccin
fi
sh
perform
establish
vaccin
actual
protect
fish
vaccin
becom
much
sophist
sinc
technolog
recombin
dna
vaccin
power
tool
vaccin
develop
leong
et
al
smith
enabl
isol
potenti
protect
antigen
suppress
one
develop
simpler
approach
use
inactiv
whole
cell
vaccin
succeed
mani
import
diseas
attempt
attenu
vaccin
gener
encourag
safeti
point
view
benmansour
de
kinkelin
ipnv
vaccin
base
recombin
express
viral
protein
develop
frost
ness
market
sever
year
use
salmon
norway
licens
recombin
vaccin
slow
dna
vaccin
fi
sh
shown
effect
base
dnasequ
encod
rhabdoviru
glycoprotein
lorenzen
la
patra
fi
rst
dna
vaccin
licens
canada
ihnv
vaccin
fi
sh
administ
varieti
differ
method
ie
inject
intramuscular
intraperiton
immers
bath
dipvaccin
oral
much
interest
develop
oral
vaccin
practic
method
administr
absenc
natur
exposur
booster
vaccin
need
maintain
immun
oral
vaccin
booster
use
success
market
commerci
exampl
oral
vaccin
avail
enter
red
mouth
erm
vibriosi
rainbow
trout
furunculosi
ipnv
salmon
meeusen
et
al
vaccin
employ
antigen
protect
vehicl
protect
vaccin
acid
environ
fi
sh
stomach
improv
deliveri
system
current
research
varieti
vaccin
close
monitor
stock
ensur
earli
detect
pathogen
caus
diseas
problem
effect
treatment
vaccin
prevent
infect
clearli
method
diseas
control
farmer
take
number
measur
manag
impact
healthi
stock
includ
improv
nutritiondiet
maintain
stock
densiti
level
optimis
growth
avoid
overcrowd
reduc
abil
anim
resist
infect
immunostimmul
eg
glucan
ad
diet
report
enhanc
immun
system
fi
sh
short
term
appli
either
vaccin
adjuv
report
affect
stimul
nonspecifi
c
defens
mechan
anim
thompson
adam
peddi
secomb
dietari
addit
also
use
sometim
target
specifi
c
diseas
eg
addit
vitamin
e
target
salmon
pancrea
diseas
spd
wide
rang
modifi
ed
diet
immunostimul
avail
commerci
mani
new
product
research
bricknel
dalmo
peddi
secomb
addit
probiot
wide
use
countri
birkbeck
reduc
risk
exposur
impact
healthi
popul
also
effect
altern
approach
pathogen
control
molecular
method
eg
pcr
ideal
technolog
use
screen
fi
sh
broodstock
egg
presenc
pathogen
long
larg
enough
sampl
size
test
eg
egg
may
prove
effect
method
reduc
reservoir
specifi
c
pathogen
fi
sh
farm
recent
manji
report
although
preval
flavobacterium
psychrophilum
rainbow
trout
egg
low
still
led
spread
diseas
rainbow
trout
fri
syndrom
rtf
mortal
egg
grown
studi
necessari
test
least
egg
per
batch
screen
process
longterm
approach
diseas
control
select
diseaseresist
strain
famili
fi
sh
much
research
current
focus
fi
sh
genotyp
diseas
suscept
biacchesi
et
al
select
breed
program
shown
larg
benefi
cial
effect
product
qualiti
trait
coldwat
fi
sh
speci
small
percentag
aquacultur
product
base
genet
improv
fi
sh
shellfi
sh
gjedrem
resist
complex
quantit
trait
like
affect
mani
gene
gjedrem
et
al
grimholt
et
al
select
diseas
resist
necessari
challeng
larg
number
anim
measur
famili
overal
perform
trait
gene
associ
diseas
stress
resist
identifi
ed
characterist
use
identifi
er
marker
select
breed
diseaseandor
stressresist
individu
moen
et
al
approach
continu
pursu
bear
mind
increas
resist
one
pathogen
result
decreas
resist
pathogen
nucleotid
sequenc
becom
avail
fi
sh
bacteri
pathogen
provid
opportun
develop
innov
altern
diseas
control
method
recent
follow
sequenc
r
salmoninarum
sudheesh
et
al
describ
identifi
cation
new
class
drug
phenyl
vinyl
sulfon
inhibit
activ
import
enzym
sortas
r
salmoninarum
inhibit
enzym
appear
dramat
reduc
virul
bacterium
interf
abil
bacterium
adher
colonis
fi
sh
cell
drug
could
offer
promis
altern
antibiot
control
bacteri
kidney
diseas
fi
sh
type
approach
hold
potenti
futur
control
bacteri
diseas
gener
fi
sh
technolog
assist
diseas
control
move
rapid
pace
care
consider
must
given
select
method
take
forward
appli
aquacultur
vaccin
need
costeffect
safe
pathogen
detect
method
robust
yet
sensit
mani
innov
technolog
may
fulfi
l
criteria
provid
new
vaccin
use
diagnost
tool
import
howev
diagnost
method
alreadi
develop
standardis
fulli
valid
consid
use
new
technolog
supersed
novel
method
need
clear
advantag
exist
method
use
aquacultur
nanotechnolog
area
explor
detect
pathogen
food
kim
et
al
clinic
veterinari
diagnost
may
prove
extrem
use
applic
diagnost
aquat
anim
nanotechnolog
gener
use
refer
materi
nanometr
howev
also
inher
materi
display
differ
properti
bulk
micrometr
larger
materi
result
size
differ
includ
physic
strength
chemic
reactiv
electr
conduct
magnet
optic
effect
technolog
offer
abil
detect
extrem
low
level
pathogen
quickli
progress
alreadi
made
identifi
cation
foodborn
pathogen
joseph
morrison
recent
focu
differ
type
sensor
detect
pathogen
immunomagnet
reduct
imr
technolog
report
detect
low
level
viru
caus
bird
fl
u
yang
et
al
method
magnet
nanoparticl
coat
antibodi
hightransitiontemperatur
superconduct
quantum
interfer
devic
use
sens
immunomagnet
reduct
reagent
nanotechnolog
also
use
conjunct
proteom
marko
et
al
may
use
technolog
identifi
marker
diseas
vaccin
antigen
immunoprotom
discuss
section
also
known
revers
vaccinolog
recent
success
use
develop
recombin
vaccin
hydrophila
carp
poobalan
technolog
approach
knockout
technolog
indic
whether
specifi
c
antigen
essenti
import
surviv
pathogen
host
method
great
potenti
futur
includ
rna
interfer
express
certain
gene
block
antisens
rna
melam
et
al
vivo
express
technolog
ivet
rainey
preston
signatur
tag
mutagenesi
saenz
dehio
inform
obtain
varieti
techniqu
combin
data
exist
literatur
identifi
potenti
vaccin
candid
antigen
clone
recombin
express
adam
et
al
deliveri
dna
vaccin
use
bacteriophag
report
success
number
anim
includ
fi
sh
skurnik
strauch
phage
particl
use
noninfecti
grow
specialis
laboratori
strain
bacteria
phage
coat
protect
vaccin
degrad
allow
host
immun
system
process
effi
cientli
march
et
al
clark
march
technolog
may
extrem
use
oral
deliveri
dna
vaccin
fi
sh
gene
sequenc
underpin
mani
new
technolog
develop
diagnost
vaccin
develop
gene
sequenc
becom
avail
pathogen
host
fi
sh
speci
microarray
develop
enabl
rapid
progress
made
fi
sh
health
control
futur
addit
refer
cite
numer
websit
provid
use
inform
advic
summaris
tabl
